Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Trends in the approval of cancer therapies by the FDA in the twenty-first century

1. Empowering effective biomarker-driven precision oncology: A call to action

   Mark Lawler, Peter Keeling, Olga Kholmanskikh +13

   Шарҳ мақолаCancer Genomics and DiagnosticsEuropean Journal of Cancer20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.review-article.000008

2. Immuno-PET Imaging of Tumor Mesothelin Expression with a Gallium-68 Radiolabeled Nanobody

   Xiaoying Lv, Yueling Deng, Xiangming Song +7

   МақолаRadiopharmaceutical Chemistry and ApplicationsMolecular Pharmaceutics20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.001170